150 related articles for article (PubMed ID: 11469288)
21. Open-label olanzapine treatment in five preadolescent children.
Krishnamoorthy J; King BH
J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive use of olanzapine in mood disorders: five case reports.
Weisler RH; Ahearn EP; Davidson JR; Wallace CD
Ann Clin Psychiatry; 1997 Dec; 9(4):259-62. PubMed ID: 9511951
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycemia from olanzapine treatment in adolescents.
Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
Mondraty N; Birmingham CL; Touyz S; Sundakov V; Chapman L; Beumont P
Australas Psychiatry; 2005 Mar; 13(1):72-5. PubMed ID: 15777417
[TBL] [Abstract][Full Text] [Related]
25. Improvement of tardive dyskinesia following treatment with olanzapine.
Lykouras L; Malliori M; Christodoulou GN
Eur Neuropsychopharmacol; 1999 Jun; 9(4):367-8. PubMed ID: 10422899
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
Domon SE; Webber JC
J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
[TBL] [Abstract][Full Text] [Related]
27. Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified.
Tateno M; Teshirogi H; Kamasaki H; Saito T
Psychiatry Clin Neurosci; 2008 Dec; 62(6):752. PubMed ID: 19068020
[No Abstract] [Full Text] [Related]
28. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
[TBL] [Abstract][Full Text] [Related]
29. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.
Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM
J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.
Potenza MN; Holmes JP; Kanes SJ; McDougle CJ
J Clin Psychopharmacol; 1999 Feb; 19(1):37-44. PubMed ID: 9934941
[TBL] [Abstract][Full Text] [Related]
31. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
[TBL] [Abstract][Full Text] [Related]
32. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
Kinon BJ; Hill AL; Liu H; Kollack-Walker S
Int J Neuropsychopharmacol; 2003 Jun; 6(2):97-102. PubMed ID: 12890301
[TBL] [Abstract][Full Text] [Related]
33. Antibodies against human putamen in adolescents with anorexia nervosa.
Harel Z; Hallett J; Riggs S; Vaz R; Kiessling L
Int J Eat Disord; 2001 May; 29(4):463-9. PubMed ID: 11285584
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case-Control Study.
Pruccoli J; Pettenuzzo I; Parmeggiani A
J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):304-310. PubMed ID: 35612433
[No Abstract] [Full Text] [Related]
35. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
[TBL] [Abstract][Full Text] [Related]
36. Treatment of preexisting diabetes with olanzapine.
Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
[No Abstract] [Full Text] [Related]
37. Olanzapine in Tourette's disorder.
Bengi Semerci Z
J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):140. PubMed ID: 10673820
[No Abstract] [Full Text] [Related]
38. Inpatient treatment has no impact on the core thoughts and perceptions in adolescents with anorexia nervosa.
Fennig S; Brunstein Klomek A; Shahar B; Sarel-Michnik Z; Hadas A
Early Interv Psychiatry; 2017 Jun; 11(3):200-207. PubMed ID: 25808049
[TBL] [Abstract][Full Text] [Related]
39. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
40. Diurnal variation in Cotard's syndrome (copresent with Capgras delusion) following traumatic brain injury.
Butler PV
Aust N Z J Psychiatry; 2000 Aug; 34(4):684-7. PubMed ID: 10954402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
